1: (ROOT (S (S (NP (NP (JJ Common) (JJ Gastrointestinal) (NNS Symptoms)) (PP (IN Of) (NP (NP (NNS COVI-19Symptoms)) (PP (IN of) (NP (DT this) (NN virus)))))) (VP (VBP are) (ADJP (JJ similar) (PP (IN to) (NP (DT the) (NN flu)))))) (, ,) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (ADJP (JJ mild) (ADJP (JJ similar) (PP (IN to) (NP (DT a) (NN cold)))))))) (CC and) (S (NP (PRP it)) (VP (MD can) (ADVP (RB even)) (VP (VB have) (NP (NP (NP (DT the) (NN resemblance)) (PP (IN of) (NP (NNS allergies)))) (VP (VBG making) (S (NP (NP (PRP it))) (ADJP (JJ hard)) (S (VP (TO to) (VP (VB know) (NP (DT the) (NN difference))))))))))) (. .)))
2: (ROOT (S (ADVP (RB However)) (, ,) (SBAR (IN while) (S (S (VP (VBG having) (NP (NP (DT a) (NN fever) (, ,) (NML (NN cough)) (CC and) (NML (NN shortness))) (PP (IN of) (NP (NN breath)))))) (VP (MD may) (VP (VB be) (NP (NP (DT the) (VBN known) (JJ classic) (NNS symptoms)) (PP (IN of) (NP (CD COVI-19)))) (ADVP (RB so) (RB far)))))) (, ,) (NP (EX there)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (NP (NP (NP (JJ gastrointestinal) (NNS symptoms)) (PP (VBG including) (NP (NN diarrhea) (CC and) (NN nausea)))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (VP (VP (VBG getting) (VP (VBN missed))) (PP (VBG according) (PP (IN to) (NP (DT a) (JJ recent) (NN study)))))))))))) (. .)))
3: (ROOT (S (NP (NP (DT The) (JJ new) (NN study)) (PP (IN from) (NP (NNP Stanford) (NNP Medicine)))) (VP (VBZ has) (VP (VBN found) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (NP (DT the) (NML (JJ upper) (JJ respiratory)) (NNS symptoms))))) (NP (NP (DT a) (JJ significant) (NN number)) (PP (IN of) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (VP (VBN infected) (PP (IN with) (NP (DT this) (NN virus))))))))))) (ADVP (RB also)) (VP (VBD suffered) (PP (IN from) (NP (NP (NN loss)) (PP (IN of) (NP (NP (NN appetite)) (, ,) (NP (NNS nausea)) (, ,) (NP (NN vomiting)) (, ,) (CC and) (NP (NN diarrhea))))))))))) (. .)))
4: (ROOT (S (S (NP (DT This)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJS earliest) (NNS studies)) (PP (IN on) (NP (JJ American) (HYPH COVI-19) (NNS patients)))))))) (, ,) (CC and) (S (S (NP (PRP it)) (VP (VBD was) (ADVP (RB very) (RB recently)) (VP (VBN published) (PP (IN in) (NP (NNP Gastroenterology))) (PP (IN with) (NP (NP (NN gastroenterology) (NNS fellows) (NML (NML (NML (NNP George) (NNP Cholankeril)) (, ,) (NP (NNP MD)) (, ,)) (CC and) (NML (NP (NNP Alexander) (NNP Podboy)) (, ,) (NP (NNP MD))))) (VP (VBG sharing) (NP (DT the) (JJ lead) (NN authorship)))))))) (, ,) (CC and) (S (NP (DT the) (JJ senior) (NN author)) (VP (VBD was) (NP (NP (NNP Aijaz) (NNP Ahmed)) (, ,) (NP (NNP MD)) (, ,) (NP (NP (NN professor)) (PP (IN of) (NP (NN gastroenterology) (CC and) (NN hepatology)))))))) (. .)))
5: (ROOT (S (`` `) (S (NP (CD COVI-19)) (VP (VBZ is) (ADVP (RB probably)) (RB not) (NP (NP (RB just) (JJ respiratory) (NNS symptoms)) (PP (IN like) (NP (DT a) (NN cough)))))) (, ,) ('' ') (NP (NNP Podboy)) (VP (VBD said)) (. .) ('' ')))
6: (ROOT (S (NP (NP (DT A) (JJ third)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (SBAR (S (NP (PRP we)) (VP (VBD studied))))))) (VP (VBD had) (NP (JJ gastrointestinal) (NNS symptoms))) (. .)))
7: (ROOT (S (NP (NP (PRP It))) (VP (VBZ 's) (ADJP (JJ possible) (SBAR (S (NP (PRP we)) (VP (MD may) (VP (VB be) (VP (VBG missing) (NP (NP (DT a) (JJ significant) (NN portion)) (PP (IN of) (NP (NP (NNS patients)) (ADJP (JJ sick) (PP (IN with) (NP (DT the) (NN coronavirus))))))) (PP (IN due) (IN to) (NP (NP (PRP$ our) (JJ current) (NN testing) (NNS strategies)) (VP (VBG focusing) (PP (IN on) (NP (NP (JJ respiratory) (NNS symptoms)) (ADVP (RB alone)))))))))))))) (. .) ('' ')))
8: (ROOT (S ('' `) (S (NP (NNP George)) (VP (VBD recognized) (ADVP (RB early) (RB on)) (SBAR (IN that) (S (SBAR (IN since) (S (NP (NNP Stanford)) (VP (VBD was) (PP (IN among) (NP (NP (DT the) (JJ first) (NNS hospitals)) (SBAR (S (VP (TO to) (VP (VB get) (NP (HYPH COVI-19) (NNS patients)) (PP (IN in) (NP (DT the) (RB ..)))))))))))) (, ,) (SBAR (IN that) (S (NP (NP (DT any) (NN type)) (PP (IN of) (NP (JJ early) (NN experience)))) (VP (MD would) (VP (VB be) (ADJP (JJ important)))))))))) (, ,) ('' ') (NP (PRP he)) (VP (VBD said)) (. .) ('' ')))
9: (ROOT (S (NP (PRP We)) (VP (VBD were) (PP (IN in) (NP (NP (DT a) (JJ unique) (NN position)) (SBAR (S (VP (TO to) (VP (VB look) (PP (IN into) (NP (NP (DT this) (NN subject)) (PP (IN of) (NP (JJ gastrointestinal) (NNS symptoms))) (PP (IN among) (NP (NP (NN coronavirus) (NNS patients)) (PP (IN at) (NP (NNP Stanford)))))))))))))) (. .) ('' ')))
10: (ROOT (S (S (NP (DT The) (NN team)) (VP (VBD had) (VP (VBN been) (VP (VBG following) (NP (NP (NP (DT the) (VBG growing) (NN body)) (PP (IN of) (NP (NP (NN research)) (VP (VBG emerging) (PP (IN from) (NP (NNP Singapore) (CC and) (NNP China))))))) (VP (VBG showing) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (NML (NNP GI) (NN tract)) (NNS symptoms))) (PP (IN in) (NP (NP (DT those)) (VP (VBN infected) (PP (IN with) (NP (DT this) (NN virus))))))))))))) (, ,) (CC but) (S (NP (PRP they)) (VP (VBD were) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (VB find) (NP (NP (NP (DT any) (NNS data)) (PP (IN on) (NP (DT this) (NN topic)))) (VP (VBG involving) (NP (JJ American) (NNS patients)))))))))) (. .)))
11: (ROOT (S (ADVP (RB Thus)) (NP (PRP they)) (VP (VBD designed) (NP (NP (PRP$ their) (JJ own) (NN study)) (VP (VBG examining) (NP (NP (NNS charts)) (PP (IN of) (NP (NP (NP (DT the) (JJS earliest) (NNS groups)) (PP (IN of) (NP (CD COVI-19) (NNS patients)))) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN treated) (PP (IN at) (NP (NNP Stanford) (NNP Health) (NNP Care))))))))))))) (. .)))
12: (ROOT (S (NP (NNS Data)) (VP (VBD was) (VP (VBN analyzed) (PP (IN from) (NP (NP (CD 116) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN confirmed) (S (VP (TO to) (VP (VB be) (VP (VBN infected) (PP (IN with) (NP (DT the) (NN virus))) (PP (IN from) (NP (NP (NNP March) (CD -24)) (, ,) (CD 2020))))))))))))) (, ,) (PP (IN with) (S (NP (DT the) (NN majority)) (VP (VBG being) (VP (VP (VP (VBN treated) (CC and) (VBN released) (PP (IN from) (NP (DT a) (NN hospital) (NN ER) (CC or) (NN clinic)))) (, ,) (SBAR (WHNP (NP (CD 33)) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD were) (VP (VBN hospitalized)))))) (CC and) (S (NP (NP (CD 8)) (PP (IN of) (NP (DT those)))) (VP (VBD were) (PP (IN in) (NP (DT an) (NML (JJ intensive) (NN care)) (NN unit))))))))))) (. .)))
13: (ROOT (S (S (NP (JJ Median) (NN age)) (VP (VBD was) (NP (CD 50)) (PP (IN with) (S (NP (NP (CD 53) (NN %)) (PP (IN of) (NP (PRP them)))) (VP (VBG being) (NP (NNS men))))))) (CC and) (S (NP (QP (RB only) (CD one)) (NN death)) (VP (VBD was) (VP (VBN reported) (PP (IN within) (NP (DT this) (NN grouping)))))) (. .)))
14: (ROOT (S (S (PP (IN In) (NP (NP (DT this) (NN grouping)) (PP (IN of) (NP (CD COVI-19) (NNS patients))))) (NP (JJ gastrointestinal) (NNS symptoms)) (VP (VBD were) (VP (VBN reported) (PP (IN by) (NP (NP (NP (CD 3.9) (NN %)) (PP (IN of) (NP (DT the) (NNS patients)))) (PP (IN with) (S (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (DT this) (NN group)))) (VP (VBG describing) (NP (PRP$ their) (NNS symptoms)) (PP (IN as) (S (VP (VBG being) (ADJP (JJ mild))))))))))))) (: ;) (S (NP (CD 22) (NN %)) (VP (VBD reported) (S (VP (VBG experiencing) (NP (NP (NN loss)) (PP (IN of) (NP (NN appetite)))))))) (, ,) (S (NP (CD 22) (NN %)) (VP (VBD experienced) (NP (NN nausea) (CC and) (NN vomiting)))) (, ,) (CC and) (S (S (NP (CD 12) (NN %)) (VP (VBD experienced) (NP (NN diarrhea)))) (PP (VBG according) (PP (IN to) (NP (DT the) (NN study))))) (. .)))
15: (ROOT (S ('' `) (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD noticed) (SBAR (SBAR (IN that) (S (NP (NP (CD 40) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBD had) (NP (NP (VBN elevated) (NNS levels)) (PP (IN of) (NP (DT an) (JJ abnormal) (NN liver) (NN enzyme))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (DT those)) (PP (IN with) (NP (JJ high) (NNS levels)))) (VP (VBD required) (NP (JJR more) (NN hospitalization)))))))) (, ,) ('' ') (NP (NNP Cholankeril)) (VP (VBD said)) (. .)))
16: (ROOT (S (PP (VBN Based) (PP (IN on) (NP (PRP$ their) (NNS findings)))) (, ,) (SBAR (IN although) (S (NP (DT this)) (VP (VBZ is) (NP (NP (JJ early) (NNS data)) (PP (IN from) (NP (DT a) (JJ single) (NN institution))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (NN indication)) (PP (IN of) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (NP (DT those)) (ADJP (VBN exposed) (PP (IN to) (NP (CD COVI-19))))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG experiencing) (NP (NP (JJ gastrointestinal) (NNS symptoms)) (CC and) (RB not) (NP (JJ just) (JJ respiratory) (NNS symptoms)))))))) (VP (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBN infected)))) (CC and) (VP (MD should) (ADVP (RB also)) (VP (VB be) (VP (VBN tested))))))))))) (. .)))
17: (ROOT (S (`` `) (S (PP (IN In) (NP (NP (PRP$ our) (JJ current) (NN cohort)) (PP (IN of) (NP (NNS patients))))) (, ,) (NP (DT all) (NNS patients)) (VP (VBD had) (NP (JJ respiratory) (NNS symptoms)) (PP (JJ prior) (PP (IN to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ gastrointestinal) (NNS symptoms)))))))) (, ,) ('' ') (NP (NNP Podboy)) (VP (VBD said)) (. .) ('' ')))
18: (ROOT (S (NP (DT No) (NNS patients)) (VP (VBD had) (NP (JJ gastrointestinal) (NNS symptoms)) (PP (PP (JJ prior) (PP (IN to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ respiratory) (NNS symptoms)))))) (CC or) (PP (IN as) (NP (NP (PRP$ their) (JJ only) (NN manifestation)) (PP (IN of) (NP (CD COVI-19))))))) (. .)))
19: (ROOT (S (ADVP (RB However)) (, ,) (NP (DT that)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (NN product)) (PP (IN of) (SBAR (WHNP (WP who)) (S (NP (PRP we)) (VP (VBD were) (VP (VBG testing))))))))) (. .)))
20: (ROOT (S (ADVP (RB Currently)) (, ,) (NP (NN testing)) (VP (VBZ is) (ADVP (RB only)) (VP (VBN offered) (PP (IN for) (NP (NP (NNS patients)) (SBAR (WHNP (WDT that)) (S (VP (VBP meet) (NP (NP (JJ specific) (NNS criteria)) (: -) (NP (NP (NNS criteria)) (SBAR (WHNP (WDT that)) (S (ADVP (RB often)) (VP (VBP require) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ pulmonary) (NNS symptoms)))))))))))))))) (. .) ('' ')))
21: (ROOT (S ('' `) (S (S (NP (PRP We)) (VP (VBD had) (S (NP (CD six) (NNS fellows)) (VP (VBG working) (ADVP (RB together)))))) (CC and) (S (NP (PRP we)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB go) (PP (IN through) (NP (DT these) (NNS charts))) (ADVP (RB pretty) (RB quickly))))))))) (, ,) ('' ') (NP (NNP Cholankeril)) (VP (VBD said)) (. .) ('' ')))
22: (ROOT (S (NP (NP (PRP It))) (VP (VBD was) (NP (NP (DT a) (JJ terrific) (NN collaboration)) (PP (IN between) (NP (NNS colleagues)))) (S (VP (TO to) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB join) (NP (NNS forces)) (S (VP (TO to) (VP (VB study) (NP (DT this) (JJ new) (NN disease))))))))))))) (. .)))
23: (ROOT (S (NP (PRP We)) (VP (VBP think) (SBAR (IN that) (S (PP (IN by) (S (VP (VBG looking) (PP (IN at) (NP (NP (NNS patients)) (ADVP (RB here) (PP (IN at) (NP (NNP Stanford))))))))) (, ,) (NP (PRP it)) (VP (MD can) (VP (VB help) (S (VP (VB improve) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (DT this) (VBG emerging) (NN disease))))))))))) (. .) ('' ')))
24: (ROOT (S (NP (DT The) (NN team)) (VP (VBZ plans) (S (VP (TO to) (VP (VB continue) (NP (PRP$ their) (NNS investigations)) (SBAR (S (VP (TO to) (VP (VB study) (NP (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NML (NNP GI) (NN tract)) (NNS symptoms))) (PP (IN in) (NP (CD COVI-19)))) (CC and) (NP (NP (DT the) (NNS implications)) (PP (IN on) (NP (NN disease) (NN severity) (CC and) (NNS outcomes)))))))))))) (, ,) (PP (VBG according) (PP (IN to) (NP (NNP Cholankeril))))) (. .)))
